Hospital Ramón y Cajal -ko ikertzaileekin lankidetzan egindako argitalpenak (7)

2022

  1. FPR2 DNA Aptamers for Targeted Therapy of Wound Repair

    Journal of Investigative Dermatology, Vol. 142, Núm. 8, pp. 2238-2248.e8

  2. First-in-human phase I clinical trial of a TLR4-binding DNA aptamer, ApTOLL: Safety and pharmacokinetics in healthy volunteers

    Molecular Therapy - Nucleic Acids, Vol. 28, pp. 124-135

2018

  1. Novel DNA Aptamers Against CCL21 Protein: Characterization and Biomedical Applications for Targeted Drug Delivery to T Cell-Rich Zones

    Nucleic Acid Therapeutics, Vol. 28, Núm. 4, pp. 242-251

  2. TLR4-Binding DNA Aptamers Show a Protective Effect against Acute Stroke in Animal Models

    Molecular Therapy, Vol. 26, Núm. 8, pp. 2047-2059

2016

  1. Characterization of MNK1b DNA Aptamers that inhibit proliferation in MDA-MB231 breast cancer cells

    Molecular Therapy - Nucleic Acids, Vol. 5, pp. e275

2013

  1. DNA Aptamers Selectively Target Leishmania infantum H2A Protein

    PLoS ONE, Vol. 8, Núm. 10

2003

  1. Selection of aptamers against KMP-11 using colloidal gold during the SELEX process

    Biochemical and Biophysical Research Communications, Vol. 308, Núm. 2, pp. 214-218